82 related articles for article (PubMed ID: 17192511)
21. [Dipeptidylpeptidase IV inhibitors and dual action PPAR-agonists].
Heinzl S
Med Monatsschr Pharm; 2006 Mar; 29(3):93-6. PubMed ID: 16550882
[No Abstract] [Full Text] [Related]
22. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
Scherbaum WA
Diabetes Obes Metab; 2009 May; 11 Suppl 2():1-2. PubMed ID: 19385977
[No Abstract] [Full Text] [Related]
23. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
Ahrén B; Winzell MS; Wierup N; Sundler F; Burkey B; Hughes TE
Regul Pept; 2007 Oct; 143(1-3):97-103. PubMed ID: 17482289
[TBL] [Abstract][Full Text] [Related]
24. Molecule of the month. Vildagilptin.
Drug News Perspect; 2006 May; 19(4):228. PubMed ID: 16823497
[No Abstract] [Full Text] [Related]
25. Three new drugs for type 2 diabetes.
Drug Ther Bull; 2008 Jul; 46(7):49-52. PubMed ID: 18603639
[TBL] [Abstract][Full Text] [Related]
26. Incretins: what does the future hold?
Edelman SV
Diabetes Technol Ther; 2005 Oct; 7(5):809-12. PubMed ID: 16241889
[No Abstract] [Full Text] [Related]
27. Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.
Torekov SS; Kipnes MS; Harley RE; Holst JJ; Ehlers MR
Diabetes Obes Metab; 2011 Jul; 13(7):639-43. PubMed ID: 21362122
[TBL] [Abstract][Full Text] [Related]
28. [Incretin mimetics and incretin enhancers for the treatment of type 2 diabetes].
Scheen AJ; Radermecker RP; Philips JC; Paquot N
Rev Med Suisse; 2007 Aug; 3(122):1884, 1886-8. PubMed ID: 17896662
[TBL] [Abstract][Full Text] [Related]
29. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.
Roy S; Khanna V; Mittra S; Dhar A; Singh S; Mahajan DC; Priyadarsiny P; Davis JA; Sattigeri J; Saini KS; Bansal VS
Life Sci; 2007 Jun; 81(1):72-9. PubMed ID: 17532347
[TBL] [Abstract][Full Text] [Related]
30. The GLP-1 system as a therapeutic target.
Edwards CM
Ann Med; 2005; 37(5):314-22. PubMed ID: 16179267
[TBL] [Abstract][Full Text] [Related]
31. Dose proportionality and the effect of food on vildagliptin, a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.
Sunkara G; Sabo R; Wang Y; He YL; Campestrini J; Rosenberg M; Howard D; Dole WP
J Clin Pharmacol; 2007 Sep; 47(9):1152-8. PubMed ID: 17656620
[TBL] [Abstract][Full Text] [Related]
32. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
Herman GA; Stein PP; Thornberry NA; Wagner JA
Clin Pharmacol Ther; 2007 May; 81(5):761-7. PubMed ID: 17392725
[TBL] [Abstract][Full Text] [Related]
33. LAF-237 (Novartis).
Barlocco D
Curr Opin Investig Drugs; 2004 Oct; 5(10):1094-100. PubMed ID: 15535431
[TBL] [Abstract][Full Text] [Related]
34. Novel "second-generation" approaches for the control of type 2 diabetes.
Rotella DP
J Med Chem; 2004 Aug; 47(17):4111-2. PubMed ID: 15293978
[No Abstract] [Full Text] [Related]
35. Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus.
Doucet J; Chacra A; Maheux P; Lu J; Harris S; Rosenstock J
Curr Med Res Opin; 2011 Apr; 27(4):863-9. PubMed ID: 21323504
[TBL] [Abstract][Full Text] [Related]
36. [New diabetes therapy in clinical trial: will need adapted insulin supply be available soon? (interview by Dr. Judith Neumaier)].
Allolio B
MMW Fortschr Med; 2004 Feb; 146(9):10. PubMed ID: 15352699
[No Abstract] [Full Text] [Related]
37. [Plasmapheresis as treatment for severe hypertriglyceridemia].
Manrique Franco K; Sánchez-Vilar Burdiel O; Aragón Valera C; Sánchez Fernández MS; Rovira Loscos A
Endocrinol Nutr; 2011; 58(6):319-20. PubMed ID: 21459058
[No Abstract] [Full Text] [Related]
38. [Modern diabetes management. DPP-4 inhibitors have been established as progress (interview by Christine Vetter)].
Gallwitz B
MMW Fortschr Med; 2010 Jul; 152(25-27):40-1. PubMed ID: 20672662
[No Abstract] [Full Text] [Related]
39. Individualising treatment for older people with diabetes.
Morley JE; Sinclair A
Lancet; 2013 Aug; 382(9890):378-380. PubMed ID: 23706758
[No Abstract] [Full Text] [Related]
40. [The SAVOR-TIMI 53 study].
Di Lenarda A; Candido R; Cioffi G; Bossi AC
G Ital Cardiol (Rome); 2014 Jun; 15(6):335-9. PubMed ID: 25072417
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
